Regulatory

The Royal Society for Public Health (U.K.) proposes new food-labeling symbols that show how many minutes of physical exercise are equivalent to the calories contained in food products.

The registry will be developed and managed by a third-party vendor, says CRN. It is planned for launch by the end of the year.

The enriched yeast ingredient with S-adenosylmethionine (SAM-e) from Gnosis SpA is now approved to claim “improvement for the joint wrongness” on the Japanese market.

Health Canada has approved Ingredion's type-2 quillaja extract for use as an emulsifying agent in a variety of food and beverage applications.

“This type of blatant illegal activity is not only disturbing, but also disruptive, to companies in the dietary supplement industry who sell reputable products,” said CRN President and CEO Steve Mister.

The latest strategies for catching botanical adulteration combine new and old testing methods.

Algae Life Sciences announced today that it has successfully petitioned FDA for a New Dietary Ingredients (NDI) notification for its astaxanthin ingredient.

The products under FDA censure are largely marketed as weight-loss supplements.

The company received the highest possible rating of “excellent.”

Can factory-direct ingredient e-commerce survive in a time of increased quality-control scrutiny for dietary supplements?

A California federal jury ruled on Monday that Coke does not owe POM $77.5 million for misleading advertising of its Minute Maid Pomegranate Blueberry 100% Fruit Juice Blend.

Will the rest of the dietary supplements industry follow GNC’s lead on GMPs?

The defeated legislation, dubbed the “DARK” Act by consumer groups, would have preempted state-mandated GMO-labeling laws.

HP Ingredients’ LJ 100 recently received a safety confirmation from Intertek and a product license granting four new health claims from Health Canada.

The U.S. Senate overwhelmingly confirmed Robert Califf, MD, as the new FDA commissioner on Wednesday.

A recent spate of FDA warning letters does not mean the emerging CBD dietary supplements market is in trouble, say insiders. But it does raise some important questions about what's fair in terms of drugs versus supplements.

What do contract manufacturers have to say about the state of the dietary supplement industry’s reputation, as well as their own role?

FDA sent warning letters to eight manufacturers of hemp CBD products earlier this month.

“It adds a new level of credibility for BLIS K12,” Blis Technologies says of FDA confirming the GRAS status of its oral-health probiotic.

The new, one-day conference will take place in Bethesda, MD on May 5.

The annual members’ meeting and breakfast will take place on March 10 during the Natural Products Expo West trade show.

Which emerging markets for probiotics should we keep an eye on?

Brassica’s Truebroc brand glucoraphanin received a “no objection” letter from FDA for its GRAS notification.

Acting FDA Commissioner Stephen Ostroff, MD, shares FDA’s accomplishments from the last year in protecting supplement consumers, as well as challenges that remain.

Does a California Supreme Court ruling give the green light to state lawsuits over organic claims?

The Vermont attorney general has authorized NSF International to verify GMO product claims under its new food-labeling law.

“This marks the start of a new era for our industry,” says CRN President and CEO Steve Mister.

The Organic Consumers Association calls the announcement “a significant win on the GMO labeling front for consumers.”